Andrew D. Schiermeier
2019
In 2019, Andrew D. Schiermeier earned a total compensation of $1.2M as Executive Vice President, Chief Operating Officer at Intellia Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Bonus | $167,200 |
|---|---|
| Option Awards | $611,897 |
| Salary | $440,000 |
| Other | $8,778 |
| Total | $1,227,875 |
Schiermeier received $611.9K in option awards, accounting for 50% of the total pay in 2019.
Schiermeier also received $167.2K in bonus, $440K in salary and $8.8K in other compensation.
Rankings
In 2019, Andrew D. Schiermeier's compensation ranked 8,316th out of 13,971 executives tracked by ExecPay. In other words, Schiermeier earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,316 out of 13,971 | 41st |
Division Manufacturing | 3,285 out of 5,692 | 42nd |
Major group Chemicals And Allied Products | 1,244 out of 2,189 | 43rd |
Industry group Drugs | 1,057 out of 1,875 | 44th |
Industry In Vitro and In Vivo Diagnostic Substances | 30 out of 77 | 61st |
Source: SEC filing on April 24, 2020.
Schiermeier's colleagues
We found four more compensation records of executives who worked with Andrew D. Schiermeier at Intellia Therapeutics in 2019.